Cabasag, Leister John S.
HRN: 14-92-39 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/02/2023
CEFTRIAXONE 1G (VIAL)
05/02/2023
05/08/2023
IV DRIP
2gms
Q24
T/c Dengue Fever With Warning Signs; Urti
Waiting Final Action
Indication: Empiric Type of Infection: PneumoniaBloodstream Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes